The genetic approach to HIV infection is still very young and a number of different stages in the viral life cycle are being studied as targets for gene therapy, using a wide variety of modalities for gene delivery. Several gene therapy protocols for AIDS have been approved and when this article is published these may be in progress. In this chapter the scientific background to these in vivo studies is reviewed.